Premium
MODIFICATION OF ESCALATED BEACOPP WITH DACARBAZINE SUBSTITUTION REDUCES TOXICITY WHILE MAINTAINING EFFICACY FOR THE TREATMENT OF ADVANCED STAGE HODGKIN LYMPHOMA
Author(s) -
Santarsieri A.,
Sturgess K.,
Brice P.,
Menne T. F.,
Osborne W.,
Creasey T.,
Ardeshna K. M.,
Behan S.,
Bhuller K.,
Booth S.,
Collins G. P.,
Cwynarski K.,
Furtado M.,
Iyenga S.,
Jones S. G.,
O'Mahony D.,
MartinezCalle N.,
McKay P.,
Nagumantry S. K.,
Rudge J. F.,
Shah N.,
Stafford G.,
Sternberg A.,
Uttenthal B. J.,
McMillan A. K.,
Follows G. A.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.109_2880
Subject(s) - medicine , procarbazine , dacarbazine , gastroenterology , perforation , surgery , stage (stratigraphy) , regimen , oncology , urology , chemotherapy , cyclophosphamide , vincristine , paleontology , biology , materials science , punching , metallurgy